Revekka Babayev is a Nephrology physician affiliated with Stamford Hospital. OpenAlex indexes 23 publications with 537 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
30 Commerce Rd
Stamford, CT 069024550
Telephone
203-324-7666Registry record last updated 18 Dec 2015.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20251 payment
- Vantive US Healthcare LLCProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
51.3%Erythropoiesis-stimulating Agent49.5%Darbepoetin alfa100%Part B, office-administered≥11 patientsSolutions for parenteral nutrition1.1%Calcium Acetate100%Part D≥13 patients+ 1 more class in this area
Cardiovascular
31.2%Angiotensin receptor blocker (ARB)6.3%Losartan Potassium65%Valsartan17%Losartan-Hydrochlorothiazide8%Olmesartan-Hydrochlorothiazide5%Olmesartan Medoxomil5%Part D<11 patientsCalcium channel blocker5.6%Amlodipine Besylate94%Nifedipine Er6%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
10.7%Vitamin D3 Analog3.7%Calcitriol100%Part D≥43 patientsSGLT2 inhibitor2.9%Jardiance58%Farxiga42%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- THE INFLUENCE OF THE MONTH OF BIRTH ON THE PRODUCTIVITY OF KAZAKH WHITE-HEADED CATTLE DETERMINED IN THE TWO-STAGE BLUP MODEL
Bulletin of Korkyt Ata Kyzylorda University
2025 - A Case of ANCA-Negative, Crescentic Glomerulonephritis Superimposed on C1q Nephropathy in a Patient with Metastatic Colon Cancer
Journal of the American Society of Nephrology
2025 - Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network
American Journal of Kidney Diseases
2023 - INFLUENCE OF DIFFERENT ENERGY DENSITIES OF ENDOVENOUS LASER ABLATION ON THE RESULTS OF VARICOSE VEINS TREATMENT IN PATIENTS WITH DIABETES MELLITUS
Bulletin of Problems Biology and Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
James Krinsley, MD
Stamford Hospital
Siobhan Dolan, MD
Stamford Hospital
David Hsi, MD
Stamford Hospital
Michael Bar, MD
Stamford Hospital
Andrew Levey, MD
Tufts Medical Center
Glenn M. Chertow
FIND
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”